University of Wisconsin and GE HealthCare expand 40-year partnership

The University of Wisconsin School of Medicine and Public Health at UW–Madison and technology company GE HealthCare have announced a 10-year strategic collaboration, extending a partnership that has spanned over 40 years. 

This ongoing collaboration goes beyond medical imaging to explore medical physics, according to an announcement from both organizations. The initiative combines UW–Madison's team of physicians, scientists, and researchers with GE HealthCare's medical technology, aiming to advance medical imaging in areas such as MRI, CT, ultrasound, interventional radiology, molecular imaging, and more.

The overarching goal is to shape the future of medical imaging, enhance the standard of care, and improve patient outcomes by incorporating advancements in artificial intelligence and digital solutions across the care continuum.

“Our enduring relationship with GE HealthCare has led to advanced clinical technologies as a result of research that we have also seamlessly translated from bench top to bedside and deployed in real-world clinical settings,” Thomas Grist, MD, chair of the Department of Radiology at UW–Madison, said in a statement. “Technology will continue to play an important role in providing the best care possible for patients. With our shared goals of improving experiences for patients and cultivating more personalized care, the work of our combined teams has the potential to impact many patients around the world for years to come.”

Over the past decade, the collaboration has yielded more than 130 research studies on scientific and technological breakthroughs. A notable example includes a peer-reviewed study using quantitative MRI for early liver disease detection. 

The UW–Madison Department of Radiology and Department of Medical Physics are actively involved in establishing an Institute of Theranostics and Particle Therapy within the UW Carbone Cancer Center, the institution says. It aims, with the help of GE HealthCare, to develop new curative cancer therapies, showcasing how research is swiftly translating into improved patient care.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.